Ashton Thomas Private Wealth LLC lifted its position in Oracle Corporation (NYSE:ORCL – Free Report) by 26.3% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 23,809 shares of the enterprise software provider’s stock after buying an additional 4,965 shares during the period. Ashton Thomas Private Wealth LLC’s holdings in Oracle were worth $6,696,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently bought and sold shares of ORCL. Swiss National Bank boosted its stake in Oracle by 7.6% in the 2nd quarter. Swiss National Bank now owns 5,093,200 shares of the enterprise software provider’s stock worth $1,113,526,000 after purchasing an additional 360,000 shares in the last quarter. Patton Fund Management Inc. raised its holdings in shares of Oracle by 626.1% in the third quarter. Patton Fund Management Inc. now owns 11,537 shares of the enterprise software provider’s stock worth $3,245,000 after buying an additional 9,948 shares during the last quarter. Private Wealth Asset Management LLC lifted its stake in shares of Oracle by 9.2% during the second quarter. Private Wealth Asset Management LLC now owns 3,817 shares of the enterprise software provider’s stock worth $835,000 after buying an additional 321 shares during the period. Soltis Investment Advisors LLC grew its holdings in shares of Oracle by 4.8% during the second quarter. Soltis Investment Advisors LLC now owns 32,937 shares of the enterprise software provider’s stock valued at $7,201,000 after buying an additional 1,515 shares during the last quarter. Finally, Cascade Investment Group Inc. purchased a new stake in shares of Oracle during the second quarter valued at $239,000. Hedge funds and other institutional investors own 42.44% of the company’s stock.
Oracle News Roundup
Here are the key news stories impacting Oracle this week:
- Positive Sentiment: Oracle Health won a multi-organization pilot in Canada for its Clinical AI Agent, validating commercial traction for Oracle’s healthcare AI products. Multiple Canadian Healthcare Organizations Select Oracle Health Clinical AI Agent
- Positive Sentiment: Oracle’s recent $25B bond offering reportedly attracted heavy demand, indicating strong investor appetite for its debt and suggesting financing channels are open. Oracle Stock (ORCL) Gains as $25B Bond Offering Attracts Heavy Demand
- Positive Sentiment: Some sell-side firms (e.g., Barclays) have reiterated bullish ratings and high price targets, implying analysts still see upside if Oracle executes its AI/data-center strategy. Barclays Reiterates Overweight on Oracle
- Neutral Sentiment: Oracle announced an equity distribution agreement and senior notes issuance to fund its plans — this provides capital but increases near-term financing activity and complexity. Oracle Bolsters Financing with Major Senior Notes Issuance
- Neutral Sentiment: Oracle continues product and go-to-market pushes (AI banking platform, enterprise AI agents) that could drive long-term growth but require heavy near-term capex. Oracle Reimagines Banking for the AI Era
- Neutral Sentiment: Strategic commentary ties Oracle’s massive data-center and power plans to a structural shift (e.g., MarketBeat piece on companies funding power and SMRs); long-term strategic rationale exists but is execution- and timeline-dependent. The Atomic Pivot: AI’s $50 Billion Power Move
- Negative Sentiment: Markets punished Oracle after management outlined plans to raise roughly $45–50B for AI infrastructure (debt and equity), stoking dilution and leverage fears and sparking the recent sell-off. Oracle (ORCL) Is Down 11.6% After Unveiling a US$45–50 Billion AI Infrastructure Capital Plan
- Negative Sentiment: Multiple law firms have filed or are soliciting clients for securities class actions tied to Oracle’s disclosures (senior notes/offering documents and the June–Dec 2025 class period), adding legal risk and headline pressure. Kessler Topaz Files Securities Fraud Class Action Against Oracle
- Negative Sentiment: Reports say banks are exploring selling billions in loans tied to Oracle’s data centers and the company may cut up to 30,000 jobs — both raise execution and integration risks and amplify downside sentiment. Oracle Stock (ORCL) Slips as Banks Explore Selling Its Data Center Loans Oracle May Slash Up to 30,000 Jobs
- Negative Sentiment: Analysts have trimmed price targets (BMO, Scotiabank among them) and commentary highlights investor anxiety about the size/timing of the capital raise and AI execution — contributing to the stock’s decline. Oracle Price Target Lowered at BMO
Insiders Place Their Bets
Analyst Ratings Changes
A number of analysts have commented on the company. Bank of America lowered their price target on Oracle from $368.00 to $300.00 and set a “buy” rating for the company in a research report on Thursday, December 11th. Morgan Stanley decreased their target price on Oracle from $320.00 to $213.00 and set an “equal weight” rating for the company in a report on Friday, January 23rd. JMP Securities reiterated a “market outperform” rating and issued a $342.00 price target on shares of Oracle in a report on Friday, October 17th. DA Davidson reduced their price target on shares of Oracle from $200.00 to $180.00 and set a “neutral” rating for the company in a research report on Thursday, December 11th. Finally, Sanford C. Bernstein dropped their price objective on shares of Oracle from $364.00 to $339.00 and set an “outperform” rating on the stock in a report on Thursday, December 11th. Three research analysts have rated the stock with a Strong Buy rating, twenty-five have issued a Buy rating, eleven have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $296.03.
Check Out Our Latest Stock Report on ORCL
Oracle Price Performance
NYSE:ORCL opened at $146.75 on Thursday. The company has a debt-to-equity ratio of 3.28, a current ratio of 0.91 and a quick ratio of 0.91. The company has a 50 day moving average price of $191.31 and a 200-day moving average price of $235.52. Oracle Corporation has a 1-year low of $118.86 and a 1-year high of $345.72. The firm has a market cap of $421.63 billion, a price-to-earnings ratio of 27.58, a price-to-earnings-growth ratio of 1.35 and a beta of 1.64.
Oracle (NYSE:ORCL – Get Free Report) last announced its quarterly earnings results on Wednesday, December 10th. The enterprise software provider reported $2.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.64 by $0.62. Oracle had a net margin of 25.28% and a return on equity of 70.60%. The firm had revenue of $16.06 billion for the quarter, compared to the consensus estimate of $16.19 billion. During the same period in the prior year, the firm posted $1.47 earnings per share. The firm’s quarterly revenue was up 14.2% compared to the same quarter last year. Equities research analysts forecast that Oracle Corporation will post 5 EPS for the current year.
Oracle Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, January 23rd. Investors of record on Friday, January 9th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.4%. The ex-dividend date was Friday, January 9th. Oracle’s payout ratio is currently 37.59%.
Oracle Company Profile
Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.
Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.
Read More
- Five stocks we like better than Oracle
- The day the gold market broke
- Buy this Gold Stock Before May 2026
- Forget AI, This Will Be the Next Big Tech Breakthrough
- Trump Planning to Use Public Law 63-43: Prepare Now
- New gold price target
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.
